Caitong International Asset Management Co., LTD Celldex Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 32 shares of CLDX stock, worth $643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32Holding current value
$643% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
188Shares Held
69.3MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$168 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$131 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$94.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$78.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$75.5 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $940M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...